DMAAR short interest
Drugs Made In America Acquisition Corp. Rights · Financial Services · Shell Companies · settlement date 2026-09-30
| Shares short | 61,118 |
|---|---|
| Change vs prior report | -27,441 (-31.0%) |
| Change over six months | +9.7% |
| Days to cover | 5.49 (sector: 2.70) |
| Average daily volume | 11,136 |
| Rank in Financial Services | not ranked (OTC, fund or thinly traded) |
DMAAR short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 61,118 | -31.0% | 5.49 | 11,136 |
| 2026-09-15 | 88,559 | -49.4% | 1.67 | 52,877 |
| 2026-08-31 | 174,839 | +125.5% | 3.55 | 49,295 |
| 2026-08-14 | 77,536 | -19.6% | 5.72 | 13,558 |
| 2026-07-31 | 96,420 | +1389.6% | 1.00 | 109,894 |
| 2026-07-15 | 6,473 | +1194.6% | 1.00 | 29,420 |
| 2026-06-30 | 500 | -57.2% | 1.00 | 50,279 |
| 2026-06-15 | 1,169 | +484.5% | 1.00 | 27,418 |
| 2026-05-29 | 200 | -96.7% | 1.00 | 60,758 |
| 2026-05-15 | 5,971 | -27.2% | 1.00 | 194,712 |
| 2026-04-30 | 8,200 | -50.9% | 1.00 | 9,398 |
| 2026-04-15 | 16,701 | -70.0% | 1.00 | 182,010 |
| 2026-03-31 | 55,735 | +51.0% | 1.00 | 121,173 |
| 2026-03-13 | 36,904 | +487.7% | 1.00 | 234,508 |
| 2026-02-27 | 6,279 | -59.4% | 1.00 | 103,735 |
| 2026-02-13 | 15,464 | +49.2% | 1.00 | 42,020 |
| 2026-01-30 | 10,366 | -2.5% | 1.00 | 25,595 |
| 2026-01-15 | 10,633 | +60.2% | 1.00 | 11,345 |
| 2025-12-31 | 6,637 | -27.5% | 2.67 | 2,486 |
| 2025-12-15 | 9,151 | +5.2% | 1.05 | 8,754 |
| 2025-11-28 | 8,703 | -59.9% | 1.00 | 20,125 |
| 2025-11-14 | 21,676 | +1.3% | 4.67 | 4,644 |
| 2025-10-31 | 21,405 | -8.5% | 1.00 | 31,998 |
| 2025-10-15 | 23,399 | +249.0% | 1.48 | 15,762 |
| 2025-09-30 | 6,704 | +15.0% | 1.00 | 87,318 |
import finzdata as yf
yf.Ticker("DMAAR").short_interest # every report since 2017
yf.Client().short_interest(["DMAAR"], start="2018-01-01")Financial Services short interest · DMAAR price history · Who owns DMAAR · All short interest